IRadimed Corp reports results for the quarter ended in December - Earnings Summary

IRADIMED

08/02/2024 17:43

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
39 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of 32 cents.  The mean expectation of three analysts for the
quarter was for earnings of 40 cents per share. Wall Street
expected results to range from 38 cents to 41 cents per share.
    * Revenue rose 17.4% to $17.45 million from a year ago;
analysts
expected $17.33 million. 
    * IRadimed Corp's reported EPS for the quarter was 36
cents​.
    * The company reported quarterly net income of $4.54
million.
    * IRadimed Corp shares had fallen by 2.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for IRadimed
Corp is
$58.00 

This summary was machine generated from LSEG data February 8 at
05:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.40           0.39           Missed
 Sep. 30 2023      0.36           0.43           Beat
 Jun. 30 2023      0.31           0.36           Beat
 Mar. 31 2023      0.28           0.30           Beat